Urticaria News and Research

RSS
Urticaria are itchy, raised red areas on the skin. Urticaria are caused by a reaction to certain foods, drugs, infections, or emotional stress. Also called hives.
Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

National Jewish Health's chronic urticaria diagnostic assay receives US patent

National Jewish Health's chronic urticaria diagnostic assay receives US patent

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

Elorac acquires world-wide rights to Cidoxepin

Elorac acquires world-wide rights to Cidoxepin

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

FDA approves Gamunex-C for primary immunodeficiency treatment

FDA approves Gamunex-C for primary immunodeficiency treatment

IV ibuprofen effective in reducing fever in hospitalized patients

IV ibuprofen effective in reducing fever in hospitalized patients

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

ISTA Pharmaceuticals announces Phase 1/2 clinical study results of bepotastine besilate nasal spray

ISTA Pharmaceuticals announces Phase 1/2 clinical study results of bepotastine besilate nasal spray

Xeomin botulinum toxin for cervical dystonia now available in the U.S.

Xeomin botulinum toxin for cervical dystonia now available in the U.S.

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

FDA approves FASLODEX 500mg dose for metastatic breast cancer in postmenopausal women

FDA approves FASLODEX 500mg dose for metastatic breast cancer in postmenopausal women

Study: IV ibuprofen decreases pain, morphine use in pre and post-operative orthopedic surgery patients

Study: IV ibuprofen decreases pain, morphine use in pre and post-operative orthopedic surgery patients

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue

Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue

US WorldMeds announces acquisition of Solstice Neurosciences for $35M

US WorldMeds announces acquisition of Solstice Neurosciences for $35M

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint